Clinical Trial Update: Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the F-18 HX4 PET tracer for detecting tumor hypoxia across multiple cancers; the trial completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Head and Neck Cancer
• Liver Cancer
• Lung Cancer
• Rectal Cancer

Drugs mentioned

• [F-18]HX4

Snippet

Sponsor: Siemens Molecular Imaging | Conditions: Head and Neck Cancer, Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-08-30